A B S T R A C T The responses of plasma aldosterone, cortisol, and corticosterone to an infusion of 75 mEq of potassium chloride over 120 min were studied in 10 normal subjects. Five subjects were fed a 10 mEq and five a 200 mEq sodium diet, while all subjects ingested 40 mEq and 200 mEq potassium sequentially. Two potassium infusions were performed in each subject when in balance on a fixed sodium intake and low and then high potassium diets.
INTRODUCTION
Previous studies have defined an important role for the potassium ion in the regulation of aldosterone secretion.
In the dog (1) and sheep (2) , infusion of potassium into the adrenal artery increased the secretion of aldosterone. In man, on low or normal sodium intakes, potassium loading has been associated with increased urinary excretion or secretion of aldosterone (3) (4) (5) (6) (7) . In man, however, acute changes in aldosterone secretion in response to small changes in serum potassium have not been documented. The present study reports the response of plasma aldosterone, cortisol, and corticosterone after an i.v. infusion of potassium chloride on varied sodium and potassium intakes.
METHODS
10 normal volunteers, eight males and two females, ages 21-34 were admitted to The Clinical Center of the Peter Bent Brigham Hospital. Complete history and physical examination and routine laboratory tests were within normal limits. All subjects denied use of drugs of any type in the weeks immediately preceding admission. Informed consent was obtained in all cases.
All subjects received a constant sodium intake during the entire hospitalization. Five subjects received a 200 mEq sodium diet and the other five received a 10 mEq sodium diet. In addition, all patients received a diet containing 40 mEq potassium during the first 6 or 7 days of hospitalization Peripheral plasma renin activity was determined at the beginning and end of the infusion. Plasma aldosterone, corticosterone, and cortisol were measured by displacement analysis techniques as previously described from this laboratory (8) . In brief, the three steroids are first separated on a Bush 5 system. The steroids are eluted and the corticosterone and aldosterone are determined by radioimmunoassay using antibodies specifically directed against these two steroids. The cortisol is measured by a competitive protein binding method similar to that described by Nugent and Mayes (9) . The ng/100 ml per 3 hr and postinfusion PRA 235±49 ng/100 ml per 3 hr. On 200 mEq sodium/200 mEq potassium, mean PRA was 290±25 ng/100 ml per 3 hr (preinfusion) and 287±25 ng/100 ml per 3 hr (postinfusion). On 10 mEq sodium/40 mEq potassium intake, mean preinfusion PRA was 1442±590 ng/100 ml per 3 hr and postinfusion PRA was 1090±207 ng/ 100 ml per 3 hr. Mean preinfusion PRA on the 10 mEq sodium/200 mEq potassium diet was 1007±169 ng/100 ml per 3 hr and postinfusion PRA was 740± 116 ng/100 ml per 3 hr.
Response of plasma cortisol and corticosterone. On all four diets, plasma cortisol showed the expected diurnal fall from the beginning of the infusion to 3 hr after the infusion. The mean value at zero time ranged from 19±2 to 23±2 /g/100 ml and 3 hr after the end of the infusion, from 6.6±1 to 12±2 ,g/100 ml (Tables   I and II , and Figs. 1 and 2) .
The mean plasma corticosterone before the infusion ranged from 0.47±0.08 to 0.91±0.11 lg/100 ml on the four diets. Like plasma cortisol, plasma corticosterone levels declined during the study with mean values at 300 min ranging from 0.17±0.03 to 0.49±0.32 lhg/100 ml.
Response of plasma aldosterone. On all four diets, there was a significant, progressive increase in plasma aldosterone concentration during the potassium infusion and a decline when the infusion was terminated. Increases in serum potassium of 0.5-1.5 mEq/liter were 40mEq POTASSIUM usually associated with significant increments in plasma aldosterone levels.
The mean, supine preinfusion plasma aldosterone levels on the 10 mEq sodium diet were significantly different (P < 0.05) on the 40 mEq potassium diet (67±16 ng/100 ml) compared with the 200 mEq potassium intake (106±10 ng/100 ml). The peak plasma aldosterone concentration at the termination of the infusion was also significantly greater (P < 0.01) on the 200 mEq potassium diet (194±34 ng/100 ml) than on the 40 mEq potassium diet (98±18 ng/100 ml). 3 hr after the infusion was terminated, plasma aldosterone had declined to preinfusion levels on the 40 mEq potassium diet. On the 200 mEq potassium diet, the postinfusion concentration (70±19 ng/100 ml) had significantly (P < 0.05) declined below the preinfusion value (106±10 ng/100 ml).
On the 200 mEq sodium diet, plasma aldosterone levels similarly increased when the potassium content of the diet was increased. The mean preinfusion value on the 40 mEq potassium diet (4.1±0.1 ng/100 ml) was significantly lower (P <0.01) than on the 200 mEq potassium diet (23±8 ng/100 ml). The peak response at the termination of the infusion on the 200 mEq potassium diet (75±17 ng/100 ml) was significantly greater (P <0.05) than on the 40 mEq potassium diet (28±5 ng/100 ml) (Table II and Figure 2 pared with 67±16 ng/100 ml on the 10 mEq sodium diet (Tables I and II) . Basal recumbent plasma aldosterone levels were 23±8 ng/100 ml (200 mEq sodium) and 106±10 ng/100 ml (10 mEq sodium) on the 200 mEq potassium diets.
Correlation of serum potassium with plasma aldosterone response. The response of plasma aldosterone to increments in serum potassium on each of the four diets was linear (Fig. 3) . However, an identical increase in serum potassium was associated with a greater increase in plasma aldosterone levels above control values when the 200 mEq potassium diet was compared to the 40 mEq potassium intake on either sodium intake.
With an increase in serum potassium of 0.5 mEq/liter, the extrapolated increments of plasma aldosterone above control levels on the 200 mEq potassium diets were 26 ng/100 ml (10 mEq sodium) and 20 ng/100 ml (200 mEq sodium) compared with 8.0 ng/100 ml (10 mEq sodium) and 6.5 ng/100 ml (200 mEq sodium) on the 40 mEq potassium intakes. The calculated slopes of these linear relationships also indicated that the 200 mEq potassium intake, regardless of sodium intake, yielded the steepest slopes. On the 10 mEq sodium/40 mEq potassium diet, the slope (16 tassium diet (52.7±7.3 ng/100 ml per mEq per liter No disturbances in QRS interval or cardiac rhythm were recorded; a 2-3 mm increase in amplitude of the T wave occurred in most subjects.
DISCUSSION
The role of the potassium ion in regulating aldosterone secretion in man has not been established. In the dog (1) and sheep (2), the i.v. infusion of potassium chloride or potassium sulfate augmented aldosterone secretion. Previous studies in man on various sodium intakes have demonstrated that aldosterone excretion or secretion increases after oral potassium loading. Since only small increments in plasma potassium were observed when subjects were potassium loaded, Cannon, Ames, and Laragh (13) speculated that the aldosterone stimulating effect of potassium loading was not related to plasma potassium levels. The present studies indicate that in normal man, small progressive increases in serum potassium ranging from 0.5-1.5 mEq/liter are associated with progressive increments in plasma aldosterone.
Previous in vivo studies in the sheep (2) and the hypophysectomized-nephrectomized dog (1) have demonstrated that potassium infusion systemically or directly into the adrenal arterial supply acutely increases the secretion of aldosterone. The latter study indicates that the stimulating effect of the potassium ion is not dependent upon the renin-angiotensin system or ACTH secretion. Additional support for a direct role of the potassium ion in stimulating aldosterone secretion includes in vitro studies utilizing rat adrenal tissue (14-17), beef adrenal slices (18, 19) , or isolated rat glomerulosa cells (20) where increasing concentrations of potassium in the incubation media increased the production of aldosterone.
Our studies provide indirect evidence that the potassium ion directly stimulates aldosterone secretion in normal man. Because plasma renin activity declined or did not change by the termination of the potassium infusion, the increase in plasma aldosterone could not be the results of increased plasma renin activity. Mild discomfort at the beginning of the potassium infusion was experienced by some of our subjects and in several patients was associated with elevated cortisol and corticosterone levels. However, in most subjects, cortisol and corticosterone levels declined in a fashion consistent with the diurnal secretion of these steroids. It is, therefore, unlikely that an increase in ACTH secretion in response to stress or even secondary to elevated potassium levels was responsible for the increased aldosterone secretion. We cannot completely exclude this possibility since ACTH levels were not measured. A previous study (21) has also described a diurnal rhythm for aldosterone in recumbent subjects with highest levels occurring at 8 a.m. and progressively declining over the course of the day. Since our studies were performed between 9 a.m. and 2 p.m., when plasma aldosterone would ordinarily be declining, these observed increases cannot be explained by a circadian rhythm. Blair-West et al. '(2) and Davis, Urquhart, and Higgins (1) have demonstrated that large decrements in serum sodium may stimulate aldosterone secretion per se or potentiate the response to a hyperkalemic stimulus. In our subjects on all four diets, serum sodium fell slightly but significantly during the infusion. The mean fall, however, was between 2 and 3 mEq/liter, hardly in the range of the hyponatremia cited previously in animal experiments which increased the secretion of aldosterone. Thus, our data support previous in vivo and in vitro studies indicating that the potassium ion can stimulate the adrenal cortex directly to secrete aldosterone.
On either a 200 mEq or 10 mEq sodium intake, mean fasting recumbent preinfusion aldosterone levels increased significantly when the potassium intake was increased. Plasma renin values not only did not increase significantly but ordinarily declined as the potassium content of the diet was increased on either sodium intake. Mean basal preinfusion plasma cortisol and corticosterone levels did not significantly change when the potassium content of the diets was altered, suggesting ACTH secretion did not change. Basal aldosterone secretion may then be regulated by serum potassium levels which usually but not invariably increased as the potassium content of the diet was increased. It is also possible that aldosterone secretion on different potassium intakes is regulated by an alteration in intracellular potassium content.
Previous studies have demonstrated modification of aldosterone secretion in response to ACTH stimulation, angiotensin infusion and potassium loading on high and low sodium intakes. A heightened aldosterone response to ACTH with sodium depletion has been reported in humans (22, 23) . High potassium intake can also augment the secretion of aldosterone in response to ACTH infusion (24) . The response of the adrenal cortex to potassium loading is also modified by the sodium and potassium balance. Cannon et al. (13) reported that the aldosterone secretory response to potassium administration was enhanced 4-to 10-fold after sodium depletion in normal subjects. The in vitro steroidogenic response of rat adrenal tissue to potassium loading was also found to be related to the previous in vivo sodium and potassium balance status of the animals (14, 15). Funder et al. (25) reported that the degree of augmentation of aldosterone secretion with potassium loading was not different, however, in sodium-repleted compared with sodium-depleted sheep. In our studies, the response of the adrenal cortex to increments in serum potassium was also related to the sodium and potassium balance of the subjects.
On the 40 mEq potassium diets, rises in serum potassium of 1-1.5 mEq/liter were always associated with significant increments in plasma aldosterone concentration. In subjects on a 200 mEq potassium intake, increments of serum potassium of only 0.5 mEq/liter were associated with significant elevations in plasma aldosterone levels. By extrapolation, a 25% increase in plasma aldosterone may occur with as little as 0.2 mEq increase in serum potassium on a 200 mEq potassium intake compared with a 0.9 mEq change on a 40 mEq potassium intake. The response of plasma aldosterone to incremental changes in serum potassium on each of the four diets was linear. However, while the preinfusion and peak plasma aldosterone levels at the end of the infusion were always greater on the 10 mEq sodium diet than on the 200 mEq sodium diet, a change in dietary sodium did not alter the slopes of the plasma aldosterone-serum potassium relationship on either potassium intake. Increasing the dietary potassium intake from 40 to 200 mEq on either sodium intake significantly increased the slopes of the lines (P < 0.01) (Fig. 3) . Thus, identical increments in serum potassium on either sodium intake produced greater increments in aldosterone secretion above control levels when the dietary potassium intake was 200 mEq rather than 40 mEq.
The dietary levels assigned to our subjects were selected to exaggerate any influence of sodium and potassium balance on the response of plasma aldosterone to potassium loading. Although the dietary potassium intakes were slightly below (40 mEq) or significantly greater (200 mEq) than the average dietary intake (50-100 mEq/day), our subjects were in balance on these diets as evidenced by their urine excretion values and normal basal serum potassium levels. Although it is unlikely that subjects on the 40 mEq potassium intake were potassium depleted, the heightened aldosterone secretion seen on the 200 mEq potassium intake could nevertheless reflect an enhanced secretion of aldosterone on the high potassium diet, a blunted response on the 40 mEq diet, or both. Since potassium infusions were not performed on normal dietary potassium intakes, this question cannot be resolved. However, since it is unlikely that the 40 mEq potassium diet produced significant potassium depletion, it may be anticipated that a slightly higher (normal) potassium intake might yield a slightly greater slope than that seen on the 40 mEq potassium diet.
In our studies, the maximal increases in serum potassium by the termination of the infusion were smaller in 9 of 10 subjects when they ingested 200 mEq of potassium daily than when they consumed 40 mEq of potassium. This could be explained by the more rapid increase in plasma aldosterone concentration on the high potassium diet, thereby facilitating potassium secretion by the distal tubular epithelium. Although urinary potassium excretion could not be measured in our subjects during the potassium infusion, previous studies in the dog (26) and rat (27) have demonstrated an enhanced renal clearance of potassium in animals potassium loaded on high potassium diets.
